It has also set an ambitious revenue target of at least Rs 600 crore in FY27, along with a net profit margin exceeding 30%.
Cupid is a premier manufacturer and brand of premium male and female condoms, water-based personal lubricants, IVD kits, deodorants and perfumes.
In its filing to the exchanges, the company claimed it continues to operate from a position of strength, supported by adequate raw material inventory and no near-term challenges from crude-derived inputs. The filing stated that raw material inventory visibility is secured for the next six months.
“Favourable currency environment, with steady USD-INR tailwinds supporting export realizations. Strong export growth outlook, with increasing traction across international markets expected to drive the next phase of expansion,” the company statement said further.
“We are pleased to close a record-breaking quarter, with performance exceeding our annual guidance on both revenue and profitability. This reflects the strength of our business model, disciplined execution, and growing global demand for our products,” Aditya Kumar Halwasiya, Chairman & Managing Director, said, commenting on the company’s performance for the financial year that ended on March 31, 2026.
“Looking ahead, we are confident of sustaining this growth momentum. With strong export tailwinds, stable input costs, and a well-secured raw material position, we are well positioned to scale our operations meaningfully over the coming years. Our focus remains on driving consistent growth, improving margins, and strengthening our global footprint as we work towards building a resilient, high-quality business,” Halwasiya said.
Cupid share price performance
Cupid shares have defied markets, delivering a whopping 600% returns over a one-year period. The price performance remains exemplary at a time when domestic equities have largely suffered. Nifty has slipped 3% in the same period while the BSE Sensex is down nearly 5%.
The stock is currently trading above its 50-day and 200-day simple moving averages (SMAs) of Rs 82 and Rs 60, respectively.
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)